The U.S. Food and Drug Administration (FDA) has granted breakthrough therapy designation to plixorafenib as a potential treatment for adults…
Marisa Horak, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Horak, MS
GYNECOLOGICAL CANCER
New Keytruda regimen OK’d in EU for hard-to-treat gynecological cancers
A new regimen using the immunotherapy Keytruda (pembrolizumab) has been approved in the European Union for use by certain…
The U.S. Food and Drug Administration (FDA) has agreed to review an application from Telix Pharmaceuticals seeking approval of…
The U.S. Food and Drug Administration (FDA) has given the green light for a first-in-human clinical trial to test a…
PANCREATIC CANCER
First-of-its-kind solid tumor cell therapy prepares to debut in China
A new CAR T-cell therapy designed to treat gastric (stomach) and pancreatic cancers will soon be available to patients in…
The U.S. Food and Drug Administration (FDA) has awarded orphan drug designation to the experimental radiation therapy rhenium Re186 obisbemeda…
GYNECOLOGICAL CANCER
Vaginal swab test using AI found to accurately detect endometrial cancer
A test that uses artificial intelligence (AI) to analyze genetic data from a vaginal swab can detect endometrial cancer with…
Caris Life Sciences has developed a genetic test that aims to simplify care for people with a group of…
PANCREATIC CANCER
Electrical therapy shows promise for metastatic pancreatic cancer
A type of electrical therapy called Tumor Treating Fields (TTFields), given in combination with chemotherapy and other medication, may help…
GYNECOLOGICAL CANCER
FDA fast tracks treatment for advanced, resistant ovarian cancer
The U.S. Food and Drug Administration (FDA) has granted fast-track designation to the experimental therapy ZW191 as a potential treatment…